COMPANY DIRECTORS and SENIOR MANAGERS
GeneMedix plc's has access to wealth of experience and expertise within its own management team and now within the enlarged Reliance Life Sciences Group.
Vinay Ranade
Chief Executive Officer
Vinay Ranade has taken over as CEO of the Company from 1 January 2008 and will be based at the Company’s offices in Ireland. Vinay Ranade, aged 40, is a Chartered Accountant and a Management Graduate by qualification and has over 17 years of experience in various fields including investment banking, finance and commercial functions, business, projects and operations. He has been a core team member in developing the biotechnology initiatives at Reliance Life Sciences since 2001. He has been associated with the Company during the acquisition process since December 2005 and has been part of the integration team since that date. In his role as CEO of GeneMedix, Vinay is responsible for ensuring that the Company’s objective of delivering high quality, cost-effective biopharmaceuticals to a global healthcare market is achieved and will be developing the infrastructure of the company following its acquisition by Reliance Life Sciences in February 2007.
Dr Ramesh Mashelkar
Chairman and Non-Executive Director
Dr. Ramesh Mashelkar is Non-executive Chairman of the Company. Dr Mashelkar is an eminent Scientist with an outstanding academic record and has held a number of very high profile positions in the field of Science and Technology. He is presently the President of the Indian National Science Academy (INSA) and President of Global Research Alliance, a network of publicly funded R&D institutes from Asia Pacific, Europe & USA with over 60,000 scientists. Prior to this he served as Director General of Council of Scientific and Industrial Research (CSIR). Dr Mashelkar has 26 honorary doctorates, and is the only third Indian engineer to have been elected as Fellow of Royal Society (FRS) London in the twentieth Century.
Mr K V Subramaniam
Executive Director
Mr K.V. Subramaniam, is the President and CEO of Reliance Life Sciences, He is a Chemical Engineer from Madras University and a Management Graduate from the Indian Institute of Management, Ahmedabad. He started his career with Indian Petrochemicals Corporation Limited, where he spent fourteen years before joining Reliance Industries Limited in 1994. At Reliance Industries he lead the corporate business development function, where he was involved in several new initiatives of the organisation in petrochemicals, power, infrastructure, agriculture and insurance. He has been instrumental in conceiving and developing Reliance Life Sciences, which has several programs covering stem cells and tissue engineering, molecular diagnostics and genetics, therapeutic proteins, biopolymers, biofuels, biochemicals, plant biotechnology, clinical research and contract research.He serves on the Board of the Institute of Chartered Financial Analysts of India (ICFAI), Hyderabad, as also on the Board of ICFAI University, Mizoram. His other Directorships are Reliance Diagnostics Pvt. Ltd. And Reliance Biofuels Pvt. Ltd.
Mr Gerhard Klement
Executive Director
Gerhard F. Klement, is CEO & President for Reliance Biopharmaceuticals. He has been with Reliance since July 2006 with a remit to establish a global Biopharmaceutical company. Prior to joining Reliance he served as VP Manufacturing and Technical Operations for Altus Pharmaceuticals, leading the manufacturing, process development, formulation and analytical operations. Mr. Klement served as Chief Technology Officer for the worldwide Biologics and Chemicals Group at Lonza, where he was responsible for new technologies and business development. From 2003 to 2005 Mr. Klement was the Head of Operations, USA and Chief Operating Officer Biopharmaceuticals, worldwide at Lonza Biologics. Previously, Mr. Klement held various positions in manufacturing and engineering at Serono and Centocor. Mr. Klement serves on the Scientific Advisory Board of the New Hampshire Chamber of Commerce and of Laureate Pharmaceuticals.
Mr Rajendra S Lodha
Non-Executive Director
Mr Rajendra S Lodha, has served for 40 years (1964-2004) as Senior Partner of M/s. Lodha & Co., Chartered Accountants having offices at New Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad and Jaipur. He qualified as a Chartered Accountant in 1963. He was the President of Federation of Indian Chambers of Commerce & Industry (FICCI), the Apex Chamber of India in its Platinum Jubilee Year 2002. He is Chairman of the M.P. Birla Group which includes Birla Corporation Limited, Universal Cables Ltd., Birla Ericsson Optical Ltd., Hindustan Gum & Chemicals Ltd Besides, the Group runs several Medical and Educational Institutions including Bombay Hospital in Mumbai and Indore, Birla Vikas Hospital, Satna and Siddhi, M.P. Birla Planetarium, Belle Vue Clinic, Priyamvada Birla Aravind Eye Hospital, South Point Schools. He is currently also serving on the Boards of Interalia, National Securities Depository Ltd. (NSDL), Indian Petrochemicals Corporation Ltd., SBI Life Insurance Co. Ltd., and Henkel India Limited. He is Trustee of Bharatiya Vidya Bhavan in U.K., Life Trustee of Bombay Hospital, the largest in Mumbai and on the Governing Council of Bhagwan Mahavir Memorial Samiti, New Delhi. Mr Lodha will head up the audit committee and has significant experience with UK public companies. His other directorships are Henry F Cockhill & Sons Ltd and Terriswood Ltd, London. Mr Lodha will also be a member of the Nomination and Remuneration Committees.
Mr Atul Dayal
Non- Executive Director
Mr Atul Dayal, is a Solicitor and has been in practice since 1974. Until March 1998, he was a partner with M/s Kanga & Co., a leading firm of Advocates & Solicitors in Mumbai and from 1st April 1998, has been practicing as the sole proprietor of M/s A.S. Dayal & Associates. For about 20 years, as the main legal Advisor to Reliance Group of companies, he has been handling legal matters of the Reliance Group of companies. His other directorships are Reliance Power Ventures Ltd, Reliance Retail Finance Ltd, Pudumjee Agro Industries Ltd, Gammon India Ltd. Mr Dayal will be a member of the Audit, Nomination and Remuneration Committees.
Senior Executive
Conor, has been General Manger in Ireland since 2001 and was appointed
to oversee the development of the Tullamore biomanufacturing facility and
to run validation programmes to GMP. Prior to joining GeneMedix, he spent
five years with Q-One Biotech Ltd, where he held the position of Director
of Biomanufacturing, this operation is now the European manufacturing HQ
for Invitrogen. Prior to this, he spent three years with Archport Ltd in
Dublin and five years with Immunogen Inc in the U.S., where he held various
managerial and technical positions relating to the development and manufacture
of monoclonal antibodies and protein therapeutics.